Next Article in Journal
Bergenin Reduces Experimental Painful Diabetic Neuropathy by Restoring Redox and Immune Homeostasis in the Nervous System
Next Article in Special Issue
Metabolic Syndrome and Reproduction
Previous Article in Journal
Plastid Transformation: How Does it Work? Can it Be Applied to Crops? What Can it Offer?
Previous Article in Special Issue
Newly Identified Regulators of Ovarian Folliculogenesis and Ovulation
Review

Metabolomic Insight into Polycystic Ovary Syndrome—An Overview

1
Department of Biopharmaceutics and Pharmacodynamics, Medical University of Gdańsk, Hallera 107, 80-416 Gdańsk, Poland
2
Department of Clinical and Experimental Endocrinology, Medical University of Gdańsk, Dębinki 7, 80-211 Gdańsk, Poland
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2020, 21(14), 4853; https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21144853
Received: 20 May 2020 / Revised: 4 July 2020 / Accepted: 7 July 2020 / Published: 9 July 2020
Searching for the mechanisms of the polycystic ovary syndrome (PCOS) pathophysiology has become a crucial aspect of research performed in the last decades. However, the pathogenesis of this complex and heterogeneous endocrinopathy remains unknown. Thus, there is a need to investigate the metabolic pathways, which could be involved in the pathophysiology of PCOS and to find the metabolic markers of this disorder. The application of metabolomics gives a promising insight into the research on PCOS. It is a valuable and rapidly expanding tool, enabling the discovery of novel metabolites, which may be the potential biomarkers of several metabolic and endocrine disorders. The utilization of this approach could also improve the process of diagnosis and therefore, make treatment more effective. This review article aims to summarize actual and meaningful metabolomic studies in PCOS and point to the potential biomarkers detected in serum, urine, and follicular fluid of the affected women. View Full-Text
Keywords: metabolomics; polycystic ovary syndrome (PCOS); metabolites; biomarkers; mass spectrometry metabolomics; polycystic ovary syndrome (PCOS); metabolites; biomarkers; mass spectrometry
Show Figures

Figure 1

MDPI and ACS Style

Rajska, A.; Buszewska-Forajta, M.; Rachoń, D.; Markuszewski, M.J. Metabolomic Insight into Polycystic Ovary Syndrome—An Overview. Int. J. Mol. Sci. 2020, 21, 4853. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21144853

AMA Style

Rajska A, Buszewska-Forajta M, Rachoń D, Markuszewski MJ. Metabolomic Insight into Polycystic Ovary Syndrome—An Overview. International Journal of Molecular Sciences. 2020; 21(14):4853. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21144853

Chicago/Turabian Style

Rajska, Anna, Magdalena Buszewska-Forajta, Dominik Rachoń, and Michał J. Markuszewski 2020. "Metabolomic Insight into Polycystic Ovary Syndrome—An Overview" International Journal of Molecular Sciences 21, no. 14: 4853. https://0-doi-org.brum.beds.ac.uk/10.3390/ijms21144853

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Back to TopTop